Dr. Reddy’s advances with arm planning to initiate Phase 2 trial of CA-170

13 Sep 2017 Evaluate

Dr. Reddy’s Laboratories is currently trading at Rs. 2189.40, up by 24.60 points or 1.14% from its previous closing of Rs. 2164.80 on the BSE.

The scrip opened at Rs. 2175.30 and has touched a high and low of Rs. 2191.00 and Rs. 2171.00 respectively. So far 6,428 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3394.95 on 28-Oct-2016 and a 52 week low of Rs. 1901.65 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 2236.00 and Rs. 2069.10 respectively. The current market cap of the company is Rs. 36,308.00 crore.

The promoters holding in the company stood at 26.78%, while Institutions and Non-Institutions held 43.38% and 13.68% respectively.

Dr. Reddy’s Laboratories’ wholly owned subsidiary - Aurigene Discovery Technologies, is planning to initiate a Phase 2 trial of CA-170, a PDL1-VISTA inhibitor to be conducted at sites in India. CA-170 is an oral small molecule targeting the immune checkpoints PDL1 and VISTA.

This was announced following the presentation of preliminary data from the initial 34 patients with cancer treated in the dose escalation stage of the Phase 1 trial of CA-170 at the European Society for Medical Oncology (ESMO) 2017 Congress by Aurigene’s collaborator and licensee of CA-170, Curis, Inc., a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer.

The trial has been conducted in the US, South Korea and Spain. The Phase 2 trial is the result of the initial safety data and preliminary evidence of clinical benefit observed in the trial.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×